289 383

Cited 0 times in

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

DC Field Value Language
dc.contributor.author박준용-
dc.contributor.author한광협-
dc.date.accessioned2020-04-13T16:53:27Z-
dc.date.available2020-04-13T16:53:27Z-
dc.date.issued2020-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/175553-
dc.description.abstractHepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherMDPI-
dc.relation.isPartOfVIRUSES-BASEL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleThe Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorEui-Cheol Shin-
dc.contributor.googleauthorJi Won Han-
dc.contributor.googleauthorWonseok Kang-
dc.contributor.googleauthorTakanobu Kato-
dc.contributor.googleauthorSeong-Jun Kim-
dc.contributor.googleauthorJin Zhong-
dc.contributor.googleauthorSeungtaek Kim-
dc.contributor.googleauthorSu-Hyung Park-
dc.contributor.googleauthorPil Soo Sung-
dc.contributor.googleauthorKoichi Watashi-
dc.contributor.googleauthorJun Yong Park-
dc.contributor.googleauthorMarc P. Windisch-
dc.contributor.googleauthorJong-Won Oh-
dc.contributor.googleauthorTakaji Wakita-
dc.contributor.googleauthorKwang-Hyub Han-
dc.contributor.googleauthorSung Key Jang-
dc.identifier.doi10.3390/v12030302-
dc.contributor.localIdA01675-
dc.contributor.localIdA04268-
dc.relation.journalcodeJ03792-
dc.identifier.eissn1999-4915-
dc.identifier.pmid32168867-
dc.contributor.alternativeNamePark, Jun Yong-
dc.contributor.affiliatedAuthor박준용-
dc.contributor.affiliatedAuthor한광협-
dc.citation.volume12-
dc.citation.number3-
dc.citation.startPageE302-
dc.identifier.bibliographicCitationVIRUSES-BASEL, Vol.12(3) : E302, 2020-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.